Hospital News and Research

RSS

Markers that cause primary liver cancer identified

Hepatocellular carcinoma (HCC) or primary liver cancer forms in the epithelial tissue of the liver and is most commonly caused by the hepatitis B virus (HBV) or hepatitis C virus (HCV). In the U.S., the National Cancer Institute (NCI) estimates that 15,000 men and 6,000 women are diagnosed with HCC each year.

21 Oct 2009

PHNS to obtain federal electronic health record stimulus funds

PHNS Inc. announced that it has been engaged by NorthBay Healthcare (NorthBay), Fairfield, California, to assess its readiness to obtain federal electronic health record stimulus funds. The American Recovery and Reinvestment Act of 2009 (ARRA) provides approximately $34 billion of federal funds for improved electronic health records and connectivity to improve patient care and quality.

21 Oct 2009

King Pharmaceuticals receives FDA complete response letter for CorVue NDA

King Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for CorVue™ (binodenoson) for injection.

21 Oct 2009

Study reveals a dramatic increase in TTB cases

Babesiosis is a potentially dangerous parasitic disease transmitted by ticks and is common in the Northeast and the upper Midwest. Babesia lives inside of red blood cells, meaning it can also be transmitted through a blood transfusion from an infected but otherwise asymptomatic blood donor.

21 Oct 2009

Purdue Pharma supports government prescription drug monitoring programs, grants NASCSA $200,000

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 25th annual conference in San Diego. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

21 Oct 2009

Kinetic Concepts announces fiscal 2009 third-quarter results

Kinetic Concepts, Inc. today reported third quarter 2009 total revenue of $504.4 million, compared to $503.3 million reported for the third quarter of 2008. Total revenue for the first nine months of 2009 was $1.466 billion, up 6% from the prior-year period. Foreign currency exchange movements negatively impacted total revenue for the third quarter and first nine months of 2009 by approximately 1% and 3%, respectively, compared to the corresponding periods of the prior year.

21 Oct 2009

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

Gunther von Hagens' Body Worlds 2 & The Brain made its debut at Philadelphia's Franklin Institute on October 17, and will be one of many points of interest for visitors eager to explore the area's vast array of scientific treasures.

21 Oct 2009

California Association of Psychiatric Technicians rally against state budget cuts

The California Association of Psychiatric Technicians is continuing a series of weekly informational pickets at state hospitals, developmental centers and prisons, this time at Patton State Hospital and Fairview Developmental Center. The events will draw attention to ongoing state budget cuts that are not only hurting employees, but also the vital services Psych Techs provide to Californians in their care.

21 Oct 2009

MUSC launches Social Media Newsroom for real-time information on medical news and research

As the editorial landscape continues to evolve with the emergence of social media, many people struggle to find trusted resources that offer accurate, real time information related to healthcare news and research.

21 Oct 2009

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and the Hon. Arthur T. Porter, Director General and CEO of the McGill University Health Centre (MUHC), welcome the news that Dr. Phil Gold is to be inducted into The Canadian Medical Hall of Fame. In 1965, Dr. Gold co-discovered the carcinoembryonic antigen (CEA), the first clinically useful human tumour marker that revolutionized the diagnosis and management of cancer.

21 Oct 2009

MIRP surgery carries higher risk of impotence and incontinence than traditional surgery

A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York.

21 Oct 2009

Study of aldosterone antagonist usage among patients hospitalised with heart failure published

A study published today in JAMA (October 21) by Nancy M. Albert and colleagues, exploring aldosterone antagonist usage among US patients hospitalised with heart failure, found that only one-third of patients meeting current US Clinical Practice Guidelines criteria were actually being treated.

21 Oct 2009

Cheering for your favorite baseball team: Is it hazardous to your health?

A study, led by cardiologist, Dr. Franklin Zimmerman of Columbia University, will use an ambulatory blood pressure monitor (ABPM) to determine whether cheering for your favorite baseball team is hazardous to your health.

21 Oct 2009

UT Physicians to open new multi-specialty clinic in Sienna Village by 2010

Weaver, Davis & Jacob (WDJ) Realty Group, a full-service commercial real estate company specializing in mixed-use property development, announced today that UT Physicians, the medical group practice of The University of Texas Medical School at Houston, has entered into a lease agreement for 8,882 square feet with plans to expand to 24,000 square feet at Sienna Village in Missouri City, TX.

21 Oct 2009

Autobiography of a cardiologist "Doctor of the Heart" published

Doctor of the Heart: My Life in Medicine is the autobiography of Isadore Rosenfeld, MD, world-renowned cardiologist, best-selling author, and popular television commentator. Published by Mary Ann Liebert, Inc., Dr. Rosenfeld's book is a remarkable account of his long and extraordinary career (www.liebertpub.com/heart).

21 Oct 2009

Sentillion bags contract from BTUH to implement its SSO solution

After demonstrating how quickly and easily its single sign-on (SSO) solution, expreSSO™, integrates with all types of healthcare applications, Sentillion today announced that it was awarded a contract with Basildon and Thurrock University Hospitals NHS Foundation Trust (BTUH). BTUH is currently deploying expreSSO in two clinical departments and will begin its enterprise deployment later this month.

21 Oct 2009

American Association for Homecare commends bipartisan lawmakers

The American Association for Homecare praised a bipartisan group of lawmakers in the House of Representatives for backing introduction of H.R. 3790, a bill to eliminate the controversial, deeply flawed "competitive" bidding program for durable medical equipment and services in Medicare.

21 Oct 2009

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Chlorothiazide Sodium for Injection, USP. APP expects to launch Chlorothiazide Sodium for Injection, USP in the fourth quarter of 2009.

21 Oct 2009

Contribution of glycosaminoglycans to skeletal abnormalities in patients with lysosomal storage diseases demonstrated

A group led by Dr. Dieter Br-mme at the University of British Columbia has demonstrated that glycosaminoglycans (GAGs) contribute to skeletal abnormalities in patients with lysosomal storage diseases. Their report can be found in the November 2009 issue of The American Journal of Pathology.

21 Oct 2009

Statewide Initiative to increase sudden cardiac arrest survival rates launched in Minnesota

Medtronic Foundation and Take Heart Minnesota™ today announced a comprehensive statewide initiative, the first in the nation, designed to increase sudden cardiac arrest (SCA) survival rates. SCA is a condition in which the heart abruptly stops without warning. More than 4,500 cases of SCA were reported in Minnesota in 2008, an average of 12.5 incidences per day.

21 Oct 2009

Hospital News and Research

Markers that cause primary liver cancer identified

PHNS to obtain federal electronic health record stimulus funds

King Pharmaceuticals receives FDA complete response letter for CorVue NDA

Study reveals a dramatic increase in TTB cases

Purdue Pharma supports government prescription drug monitoring programs, grants NASCSA $200,000

Kinetic Concepts announces fiscal 2009 third-quarter results

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

California Association of Psychiatric Technicians rally against state budget cuts

MUSC launches Social Media Newsroom for real-time information on medical news and research

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

MIRP surgery carries higher risk of impotence and incontinence than traditional surgery

Study of aldosterone antagonist usage among patients hospitalised with heart failure published

Cheering for your favorite baseball team: Is it hazardous to your health?

UT Physicians to open new multi-specialty clinic in Sienna Village by 2010

Autobiography of a cardiologist "Doctor of the Heart" published

Sentillion bags contract from BTUH to implement its SSO solution

American Association for Homecare commends bipartisan lawmakers

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

Contribution of glycosaminoglycans to skeletal abnormalities in patients with lysosomal storage diseases demonstrated

Statewide Initiative to increase sudden cardiac arrest survival rates launched in Minnesota

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News